This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Jonathan Watts, PhD
Professor at UMass Chan Medical School
Speaker

Profile

Jonathan Watts is Professor at the RNA Therapeutics Institute of UMass Chan Medical School (Worcester, MA). He completed his PhD in chemistry from McGill University and did postdoctoral work in biochemistry and pharmacology at UT Southwestern Medical Center. Work in the Watts lab is mainly focused on the optimization of oligonucleotide therapeutics for use in the brain and lung, and on increasing the efficacy and versatility of genome editing for therapeutic use. The Watts group works on both platform technology and disease applications, and has contributed to the development of multiple oligonucleotide drugs that have reached ALS patients on a compassionate use basis.

Agenda Sessions

  • Novel Chemistries in Gene Silencing and Prime Editing

    11:15am